997921897	997921897	CD	B-NP	O
|	|	NN	I-NP	O
MMH	MMH	NN	I-NP	O
|	|	NN	I-NP	O
62172046	62172046	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8671687	8671687	CD	B-NP	O
|	|	CC	I-NP	O
5/21/2006	5/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
FEVER	FEVER	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/21/2006	5/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2006	10/21/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DUMPERT	DUMPERT	NN	B-NP	O
,	,	,	O	O
BASIL	BASIL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Ri	Ri	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
September	September	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Warneka	Warneka	NNP	I-NP	O
Postoperative	Postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
since	since	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
diff	diff	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Wooda	Wooda	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-VP	O
rehabilitation	rehabilitation	VB	I-VP	O
facility	facility	NN	B-NP	O
on	on	IN	B-PP	O
10/4/06	10/4/06	CD	B-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Cipro	Cipro	NN	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Luke	Luke	NNP	I-NP	O
's	's	POS	B-NP	O
Ca	Ca	NNP	I-NP	O
Health	Health	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
clinically	clinically	RB	B-ADVP	O
until	until	IN	B-SBAR	O
about	about	IN	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
lethargic	lethargic	JJ	B-ADJP	O
with	with	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
substernal	substernal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
intermittent	intermittent	JJ	I-ADJP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
arm	arm	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
was	be	VBD	B-VP	O
described	describe	VBN	I-VP	O
as	as	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
,	,	,	I-NP	O
constant	constant	JJ	I-NP	O
and	and	CC	O	O
3/10	3/10	CD	B-NP	O
in	in	IN	B-PP	O
intensity	intensity	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
was	be	VBD	B-VP	O
nonexertional	nonexertional	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
persistently	persistently	RB	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
without	without	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
mediastinitis	mediastinitis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Thoracic	Thoracic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
cleared	clear	VBN	B-VP	O
.	.	.	O	O

ED	ED	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Echo	Echo	NNP	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NNP	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
plus	plus	CC	O	O
Flagyl	Flagyl	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
given	give	VBN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
500	500	CD	I-NP	O
mL	mL	NN	I-NP	O
normal	normal	JJ	I-NP	O
saline	saline	NN	I-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Partial	Partial	JJ	B-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1970s	1970	NNS	I-NP	O
,	,	,	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
in	in	IN	B-PP	O
1970s	1970s	CD	B-NP	O
and	and	CC	I-NP	O
inguinal	inguinal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
10/22	10/22	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
3/22	3/22	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Mitral	Mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
repair	repair	NN	I-NP	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
fatty	fatty	JJ	B-NP	O
liver	liver	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
of	of	IN	B-PP	O
hips	hip	NNS	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
nodule	nodule	NN	I-NP	O
on	on	IN	B-PP	O
10/11/04	10/11/04	CD	B-NP	O
by	by	IN	B-PP	O
CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
,	,	,	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
omeprazole	omeprazole	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
thyroiditis	thyroiditis	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
kidney	kidney	NN	B-NP	O
stone	stone	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
mammogram	mammogram	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Ischemic	Ischemic	JJ	B-NP	O
cardiopathy	cardiopathy	NN	I-NP	O
myopathy	myopathy	NN	I-NP	O
with	with	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurg	regurg	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	O
but	but	CC	O	O
defects	defect	VBZ	B-VP	O
on	on	IN	B-PP	O
SPECT	SPECT	NN	B-NP	O
and	and	CC	I-NP	O
MRI	MRI	NN	I-NP	B-protein
,	,	,	O	O
subendocardial	subendocardial	JJ	B-NP	O
MI	MI	NN	I-NP	O
on	on	IN	B-PP	O
10/24/06	10/24/06	CD	B-NP	O
per	per	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
AFib	AFib	NN	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	O	O
sedentary	sedentary	JJ	B-NP	O
lifestyle	lifestyle	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Advair	Advair	NN	B-NP	O
250/50	250/50	CD	B-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	O
for	for	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
,	,	,	O	O
Gemfibrozil	Gemfibrozil	NNP	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
175	175	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
causes	cause	VBZ	B-VP	O
angioedema	angioedema	NN	B-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
causes	cause	VBZ	B-VP	O
hives	hive	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Former	Former	JJ	B-NP	O
bus	bus	NN	I-NP	O
driver	driver	NN	I-NP	O
.	.	.	O	O

Divorced	Divorce	VBN	B-VP	O
with	with	IN	B-PP	O
10	10	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
visit	visit	VBP	B-VP	O
.	.	.	O	O

LIVING	LIVING	VBG	B-VP	O
SITUATION	SITUATION	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
apartment	apartment	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
involved	involve	VBN	I-ADJP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
110s	110	NNS	I-NP	B-DNA
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
15	15	CD	B-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	I-NP	O
sleepy	sleepy	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
of	of	IN	B-PP	O
respiration	respiration	NN	B-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
neck	neck	NN	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Irregular	Irregular	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

abdomen	abdoman	NNS	B-NP	O
:	:	:	O	O
Mild	Mild	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Grossly	Grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
with	with	IN	B-PP	O
pulse	pulse	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
over	over	IN	B-PP	O
creatinine	creatinine	NN	B-NP	B-protein
12/0	12/0	CD	I-NP	I-protein
.9	.9	NN	I-NP	I-protein
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
126	126	CD	I-NP	I-protein
,	,	,	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.8	8.8	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.7	3.7	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
over	over	IN	B-PP	O
ALT	ALT	NN	B-NP	B-protein
15/7	15/7	CD	I-NP	I-protein
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
39	39	CD	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
11.5	11.5	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
33.6	33.6	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.6	1.6	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
131	131	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
by	by	IN	B-PP	O
aVL	aVL	NN	B-NP	O
criteria	criterion	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve/tricuspid	valve/tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NN	I-NP	O
colitis	colitis	NN	I-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fatigue	fatigue	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	I-VP	O
likely	likely	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
persistent	persistent	JJ	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NN	I-NP	O
related	related	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
became	become	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
intermittent	intermittent	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
NSVT	NSVT	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
under	under	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
chest	chest	RB	B-ADJP	O
pain-free	pain-free	JJ	I-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
,	,	,	I-NP	O
statin	statin	NN	I-NP	O
and	and	CC	I-NP	O
gemfibrozil	gemfibrozil	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
biomarkers	biomarker	NNS	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
rehydrated	rehydrate	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
overhydration	overhydration	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	I-ADVP	O
finally	finally	RB	I-ADVP	O
per	per	IN	B-PP	O
cardiology	cardiology	NN	B-NP	B-protein
recommendation	recommendation	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.o.	p.o.	FW	I-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Diltiazem	Diltiazem	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
improved	improve	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
with	with	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
IV	IV	CD	I-NP	O
hydration	hydration	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
2.6	2.6	CD	B-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
cardiology	cardiology	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
75	75	CD	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NN	B-NP	O
300	300	CD	I-NP	O
daily	daily	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
NSVT	NSVT	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
her	her	PRP	B-NP	O
some	some	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
frightening	frightening	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
cardiology	cardiology	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
post-discharge	post-discharge	JJ	B-ADJP	O
and	and	CC	O	O
then	then	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Toprol	Toprol	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
per	per	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
LMR	LMR	NN	B-NP	B-protein
for	for	IN	B-PP	O
formal	formal	JJ	B-NP	O
report	report	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
and	and	CC	O	O
C.	C.	FW	B-NP	O
diff	diff	FW	I-NP	O
colitis	colitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
use	use	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
for	for	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	CC	O	O
positive	positive	JJ	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NNP	B-NP	O
became	become	VBD	B-VP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
9/2/06	9/2/06	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
rapidly	rapidly	RB	B-VP	O
slowed	slow	VBD	I-VP	O
on	on	IN	B-PP	O
dual	dual	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
seven	seven	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Synthroid	Synthroid	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
initially	initially	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
rechecked	rechecke	VBN	B-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Synthroid	Synthroid	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Niferex	Niferex	NNP	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
Coumadin	Coumadin	NNP	B-NP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
pretest	pretest	JJ	I-NP	O
probability	probability	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
PECT	PECT	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
V/Q	V/Q	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
1/19/06	1/19/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
result	result	NN	I-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
exam	exam	NN	I-NP	O
improved	improve	VBN	B-VP	O
greatly	greatly	RB	B-ADVP	O
on	on	IN	B-PP	O
b.i.d.	b.i.d.	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
plus	plus	CC	O	O
proton	proton	NN	B-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
eat	eat	VB	I-VP	O
solid	solid	JJ	B-NP	O
foods	food	NNS	I-NP	O
and	and	CC	O	O
tolerated	tolerate	VBN	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
post-discharge	post-discharge	JJ	B-ADJP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Raycennant	Raycennant	NNP	B-NP	O
Dehey	Dehey	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Stop	Stop	NN	B-NP	O
Diltiazem	Diltiazem	NN	I-NP	O
and	and	CC	I-NP	O
metoprolol	metoprolol	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Start	Start	NNP	B-NP	O
Toprol-XL	Toprol-XL	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
until	until	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
5/29/06	5/29/06	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
switch	switch	VB	B-VP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
LFTs	LFT	NNS	I-NP	O
and	and	CC	O	O
TSH	TSH	NN	B-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
weekly	weekly	RB	B-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
.	.	.	O	O

CONTINUING	CONTINUING	VBG	B-VP	O
CARE	CARE	NN	B-NP	O
PLANS	PLANS	NN	I-NP	O
FOR	FOR	IN	B-PP	O
MD	MD	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	B-protein
p.o.	p.o.	NN	I-NP	I-protein
until	until	IN	B-PP	I-protein
12/10/06	12/10/06	CD	B-NP	I-protein
,	,	,	O	O
stop	stop	NN	B-NP	O
on	on	IN	B-PP	O
8/11/06	8/11/06	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Check	Check	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
adding	add	VBG	I-VP	O
p.o.	p.o.	FW	B-NP	O
magnesium	magnesium	NN	I-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
repletion	repletion	NN	I-NP	O
after	after	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
resolves	resolve	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
INR	INR	NNP	I-NP	O
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
accordingly	accordingly	RB	B-ADVP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Check	Check	NN	B-NP	O
TSH	TSH	NN	I-NP	O
and	and	CC	O	O
LFTs	LFT	NNS	B-NP	B-protein
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
thereafter	thereafter	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	B-protein
400	400	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Advair	Advair	IN	B-PP	O
250/50	250/50	CD	B-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
5	5	CD	B-NP	O
.	.	.	O	O

Gemfibrozil	Gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
175	175	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
before	before	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
FOLLOWUP	FOLLOWUP	NN	I-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Vito	Vito	NNP	I-NP	O
Mlenar	Mlenar	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
7/9/07	7/9/07	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Kossack	Kossack	NNP	I-NP	O
of	of	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
at	at	IN	B-PP	O
051-469-9935	051-469-9935	CD	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
with	with	IN	B-PP	O
appointment	appointment	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
should	should	MD	B-VP	O
see	see	VB	I-VP	O
cardiologist	cardiologist	NN	B-NP	B-protein
next	next	IN	B-NP	I-protein
week	week	NN	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Vineper	Vineper	NNP	B-NP	O
Lo	Lo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
will	will	MD	B-VP	O
contact	contact	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-7879237	5-7879237	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LADEWIG	LADEWIG	NNP	B-NP	O
,	,	,	O	O
SHAD	SHAD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MIHALAK	MIHALAK	NN	B-NP	O
,	,	,	O	O
JACQUES	JACQUES	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6712295	6712295	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/25/06	7/25/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/25/06	7/25/06	CD	B-NP	O

